Research Site

Paris, Paris 75877

1 studies enrolling now · 5 studies all time

What they study most

Hypophosphatasia (HPP), Idiopathic Pulmonary Fibrosis, Prostate Cancer, Systemic Lupus Erythematosus

Studies at this site

• Registry of Patients With Hypophosphatasia — Enrolling by invitation
• Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS) — Completed
• An Efficacy and Safety Study of BG00011 in Participants With Idiopathic Pulmonary Fibrosis — Stopped early
• A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Hormone Resistant Prostate Cancer With Bone Metastases — Completed
• A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate Cancer — Completed